London: Scientists have hailed as yet another "penicillin moment" the successful clinical trial of a new drug that could halt or reverse the growth of cancer in the human body.
The trials of a drug developed by the US scientists have raised hopes that drug manufacturers will be able to tailor drugs to individual cancers that will halt them in their tracks and even reverse the growth of existing tumours, The Daily Telegraph reported.
As part of the latest research, scientists in California developed a drug to block the effects of a specific gene mutation, B-RAF, linked to malignant melanoma - one of the deadliest cancers.
The experts found that tumours shrank by at least 30 per cent in 24 out of 32 patients with B-RAF mutations, and disappeared entirely in two other patients.
Read more >>